Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joseph Biederman, M.D.

Co-Author

This page shows the publications co-authored by Joseph Biederman and Joseph Gonzalez-Heydrich.
Connection Strength

2.364
  1. Comparing stimulant effects in youth with ADHD symptoms and epilepsy. Epilepsy Behav. 2014 Jul; 36:102-7.
    View in: PubMed
    Score: 0.579
  2. Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy. Neuropsychiatry (London). 2012 Oct 01; 2(5):385-391.
    View in: PubMed
    Score: 0.515
  3. Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav. 2010 Jul; 18(3):229-37.
    View in: PubMed
    Score: 0.437
  4. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav. 2007 May; 10(3):384-8.
    View in: PubMed
    Score: 0.351
  5. No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series. J Child Adolesc Psychopharmacol. 2004; 14(2):295-310.
    View in: PubMed
    Score: 0.281
  6. Linkage analysis of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 05; 147B(8):1387-91.
    View in: PubMed
    Score: 0.099
  7. Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia. J Anxiety Disord. 2008; 22(1):88-97.
    View in: PubMed
    Score: 0.087
  8. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2001; 11(3):239-50.
    View in: PubMed
    Score: 0.014
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.